The importance of vitamin D on bone health and osteoporosis was studied by many researchers. The main role of the Vitamin D is to absorb calcium and phosphate and increase bone mineralization. Older people are at an increased risk of the inadequate vitamin D production in the skin because of lower sun exposure and reduced ability of the skin to synthesize vitamin D. Objective The aim of this clinical trial was to evaluate the efficacy and tolerability of short-term (2 weeks) low energy UVB irradiation in postmenopausal women with osteoporosis using bone mineral density and bone turnover markers. Methods A three-month, single-blinded, randomized, placebo-controlled clinical trial was conducted at the University hospital in Daegu, Republic of Korea. Fifty-two postmenopausal Korean women (older than 65 years) with osteoporosis were randomly allocated to have either low energy UVB or placebo for 30 minutes a day for two weeks of treatment during winter. Laboratory analysis and physical examination before and 4, 8 and 12 weeks after treatment were carried out and BMD was measured before and 8 and 12 weeks after treatment. The effects of time and treatment interaction between these two groups were evaluated by repeated-measure two-factor analysis, and subgroup analysis was performed to examine UVB effect on the vitamin D insufficient group [serum 25(OH)D 3 concentration <30 ng/mL]. Results In vitamin D insufficient group, the effect of UVB irradiation on vitamin D and bone ALP as well as additional benefit on bone formation was confirmed. The vitamin D insufficient group showed statistically significant increment in serum 25(OH)D 3 compared with the normal group (p<0.05). However, there was no significant difference between two groups in the other bone turnover markers, such as serum calcium, PTH-C, serum osteocalcin, serum CTX and BMD. Conclusion Low-energy-short-term UVB radiation for postmenopausal women may be of use in vitamin D synthesis. There was a modest benefit in change of bone ALP especially in women with the insufficient vitamin D.
INTRODUCTION
Osteoporosis has emerged as an important metabolic bone disease globally. The percentage of elderly people over 65 years was 3.4 in 1975, 6 .8 in 2000 and will be 17% of the world's population by 2050. Based on the population growth, the current incidence of osteoporosisrelated fractures in Asia became a significant public health burden [1] .
The best treatment option for osteoporosis is prevention by increasing the maximal bone quantity before menopause to decrease the risk of fractures in postmenopausal women [2] .
The importance of vitamin D on bone health was studied by many researchers. They suggested vitamin D as a hormone-like material which acts on bone, the intestines and parathyroid.
The main role of the vitamin D is to absorb calcium and phosphate and increase bone mineralisation [3, 4] .
Older people are at an increased risk of inadequate vitamin D production in the skin because of diminished sun exposure and reduced ability of the skin to synthesize vitamin D [5] . The resulting vitamin D insufficiency may have negative effects on maintenance of bone mass. There have been many studies showing that calcium and vitamin D supplementation reduces bone loss and has beneficial effect on bone metabolism [6, 7] . Some researchers advocate additional effects of vitamin D in the presence of high calcium intake [8, 9] .
Although the role of sun rays has been emphasized by many researchers [3] [4] [5] [6] , there have been few studies describing the role of ultravio-let light in the elderly population with clinically confirmed osteoporosis in terms of bone mineral density and bone turn over biomarkers in the clinical setting [5, 6] . Furthermore, there are few data on relative effects of ultraviolet B (UVB) in the elderly osteoporotic patients with vitamin D insufficiency [10] .
OBJECTIVE
The purpose of this study is to evaluate the efficacy and tolerability of short-term ultraviolet B(UVB) irradiation in the elderly osteoporotic Korean population. This report presents a single-blinded, randomized, placebo-controlled clinical trial of the effects of UVB irradiation on bone mineral density (BMD) and bone turnover markers in postmenopausal women with osteoporosis.
METHODS

Study design
One hundred and ten ambulatory, late postmenopausal (>65 year) women were enrolled in the study. Subjects were excluded who had 1) a history of cancer within the 5 years before the study, 2) a medical disease such as chronic renal failure or Cushing disease, or 3) any condition that might interfere with the evaluation of BMD (e.g., spinal fusion, treatment with systemic steroid, previous fracture of hips or spine). Any participant consuming vitamin D or calcium supplement was excluded. All participants were requested to have BMD study and confirmed osteoporosis based on World Health Organization (WHO) criteria (Tscore below -2.5).
We hypothesized that UVB radiation could affect bone formation. Therefore, bone alkaline phosphatase (ALP) became the primary endpoint in this study. For sample size determination, significance level(α)=0.05, power(1-β)=0.80 and mean difference of bone ALP between groups was 0.05, SD=0.06 [11] and 10% drop out rate were used. Each group consisted of 26 individuals.
All random codes were generated by the medical statistician using the computer programme, which the other researchers involved in the study were not able to access. Fifty-two subjects were randomly assigned to receive either ultraviolet light lamp or placebo (florescent light lamp) (Scheme 1).
The study was approved by the Kyungpook National University Hospital IRB (Institutional Review Board). The informed consent was obtained from all participants before inclusion into the study.
Treatment
The experimental group was exposed to low energy UVB (Senia®, NB Tech, Korea) at wavelength between 280 and 400 nm on the abdomen and the thigh for 30 minutes a day for 2 weeks. The control group was exposed to fluorescent lamp in the same setting. The distance between the lamp and abdomen was 100 cm. The of the ultraviolet lamp was 4.0-5.0 μw/cm 2 and it was 0.01 μw/cm 2 for the fluorescent lamp. A serological examination was carried out before treatment and 4, 8, and 12 weeks after treatment between 09 a.m. and 11 a.m. after overnight fasting to control the circadian rhythm. A radiological examination was performed before treatment and 8 and 12 weeks after treatment. All subjects took a calcium tablet daily (Mycal®, Myungmun, 1000 mg/day) without limitation of food intake or daily activities (for one month) for preventing bone loss during this study.
Biochemical bone markers
Fasting bone specific alkaline phosphate (Bone ALP) and osteocalcin (OC) were measured as bone formation markers. 
Statistical analysis
Biochemical markers before treatment and 4, 8, and 12 weeks after treatment, and biomechanical markers before treatment, and 8 and 12 weeks after treatment in each group were analysed with repeated-measure two-factor analysis. All data were referred to as mean ± standard error (SE).
The statistical package SPSS for Windows ver. 14.0 was used for the analysis. The level of statistical significance was set at p-value less than 0.05.
RESULTS
The demographic and baseline characteristics of the population were shown in Table 1 . There were no significant differences between the UVB irradiation group and the control group in baseline characteristics.
Biochemical bone markers
Changes of bone specific ALP (bone ALP): No statistical significance was found in either percentage change or results of the quantitative analysis between two groups (p>0.05) (Graph 1A).
Changes of the serum 25 hydroxy-vitamin D 3 [25 (OH) D 3 ]: At weeks 4 and 8 after the UVB irradiation, the serum level of 25 (OH)D 3 in the UVB group was significantly increased compared with the controls. Particularly, at 4 weeks after the UVB irradiation, the mean(±SE) of the UVB group was 1.07 (±0.06)%, which was significantly higher than that of the control group, 0.85 (±0.06)%. There was a statistically significant difference between two groups in the change of the serum 25 (OH)D 3 level from the baseline (p<0.05) (Graph 1B). Changes of the serum calcium level: There was no statistically significant difference between these two groups in values of the serum calcium level (p>0.05) (Graph 1C).
Changes of the serum C-terminal PTH (PTH-C) level: There was no statistically significant difference between two groups in changes of the serum PTH-C level over time (p>0.05) (Graph 1D).
Changes of the serum osteocalcin (OC) level: There was no statistically significant difference between two groups in changes of the serum OC level over time (p>0.05) (Graph 1E).
Changes of the serum C-terminal telopeptide of type I collagen (CTX): There was no statistically significant difference between two groups in change of the serum CTX level over time (p>0.05) (Graph 1F).
Bone mineral density
Lumbar vertebrae: There was no statistically significant difference between two groups in terms of percent changes over time (p>0.05) (Graph 1G).
Femur: At 8 weeks after the UVB irradiation, the percent change of BMD of the proximal femur in the experimental group was 1.03 (±0.04)%, which was slightly higher than in the controls, 0.97 (±0.04)%. However, there was no statistically significant difference between two groups in percent changes of BMD of the proximal femur over time (p>0.05) (Graph 1H).
Subgroup analysis
Based on published studies [7, 8] , the subjects in the experiment group (UVB group) were divided into two subgroups: if the initial serum 25(OH)D 3 level was below 30 ng/mL, the subject was assigned to the vitamin D insufficient group (n=8); and if the level was above 30 ng/mL, the subject was assigned to the vitamin D normal group (n=16).
Biochemical bone markers: The vitamin D insufficient group showed statistically significant increment in serum levels in the 25(OH)D 3 compared with the vitamin D normal group. Serum 25(OH)D 3 was significantly higher in the insufficient group than in the normal group. Data are mean (SD) unless otherwise specified. All women were Korean, and the mean age was 68.9 years. There were no recorded adverse events during the study period.
DISCUSSION
Traditional UVB phototherapy with high intensity of illumination (about 20W) was mainly used for skin disorders such as psoriasis, atopic dermatitis and vitiligo [12, 13] . However, this high-intensity UVB can cause adverse effect such as skin cancer and cataract [14] . This study used low illumination intensity UVB device (2.62W). When the distance between lamp and bed reached 100 cm, it dropped to 4.0-5.0 μw/cm 2 , and could result in adverse effect. Recently, Cicarma et al. [15] have reported the effect of low-dose UVB treatment; however, there have been few randomized controlled studies investigating the effect of low energy UVB treatment on patients with the postmenopausal osteoporosis.
One of the most important causes of osteoporosis in the elderly population is vitamin D deficiency, which is essential for normal calcium and bone metabolism [16] . The main source of Vitamin D is sunlight exposure, but a number of factors, such as latitude, season, time of day and use of topical sunscreen influence the cutaneous production of vitamin D [6, 17] .
In Korea, despite of the presence of abundant sunlight, Yoon et al. [18] reported potential vitamin D deficiency and its related bone diseases in menopausal women. The percentage of women with serum level of 25(OH)D below 12 ng/ml was 57.2% (out of a total of 276 women). Roy et al. [19] wrote that a number of South Asians had symptoms of vitamin D deficiency; and, in particular, individuals with the values below 15 ng/ml presented with the increased PTH and decreased BMD. Another study reported a correlation between vitamin D, calcium supply and secondary hyperthyroid condition [8, 9, 20] . They reported that serum calcium and phosphate were significantly higher in vitamin D and calcium intake group than in the placebo group.
There are two types of vitamin D production in vivo: approximately 10% of vitamin D requirement derives from food intake; more than 90% of vitamin D requirement is from exposure to sunlight [21] . With age, the vitamin D demand is being increased. However, elderly women can produce only one-third of vitamin D as compared to young women [6, 7, 10] . Holick [17] reported that 295-300 nm of the artificial UVB radiation accelerated vitamin D formation in the skin. The advantage of using UVB was to reduce side effects of medication as well as its low cost and easy application.
Previous studies reported that exposure of 20% of body to either direct sunlight or tanning bed radiation was effective in increasing the serum vitamin D 3 in both young and old populations [3, 4, 5, 22] . Indeed, Chuck et al. [4] suggested that the use of UVB lamps in nursing homes was the most effective method of maintaining the serum concentration of 25(OH)D.
This study showed the increased serum level of 25(OH) D 3 in the UVB irradiated group compared to the controls, particularly in the vitamin D deficiency subgroup of the UVB irradiated group. Bone ALP and Vitamin D were also increased significantly compared to the control group.
This study analyzed the effect of low energy UVB on bone turnover markers and change of BMD in postmenopausal osteoporotic women for 12 weeks after the treatment period. The bone ALP and other bone formation markers were slightly higher in the experimental group but there was no significant difference during the first four weeks.
When the skin is exposed to UVB with the wavelength between 219 and 315 nm, 7-dehydrocholesterol in the dermal layer is activated and converted to previtamin D 3 . Pre-vitamin D 3 then spontaneously isomerizes to cholecalciferol (vitamin D 3 ) and subsequently it undergoes sequential hydroxylation to calcifediol (25(OH)D 3 ) in the liver and calcitriol (1,25 (OH) 2 D 3 ) in the kidney, which is the major circulating form and the best indicator of vitamin D because of its short half-life [17, 23] . In this study, a sharp increase in 25(OH)D 3 was observed in the experimental group, which was statistically significant. Especially, when the results were compared between the baseline and postirradiation at 4 weeks using the two-sample t-test, the response was higher in the UVB group (45%) than in the controls (16%).
The PTH secretion was activated by low serum calcium rate, and it appeared that the higher serum PTH rate, the faster bone turnover rate. In a recent study, the PTH-C synthesized in the thyroid yielded five times higher level in circulation than intact PTH. It was cleared predominantly through the kidneys compared to intact PTH, which was cleared through the liver and kidneys [24] . Accordingly, if there were renal problems, PTH-C would be higher in the blood and take part in bone physiological activation [25] . In this study, there was little change in serum PTH-C and calcium over 12 weeks. This could be owing to homeostasis of the calcium as a normal body mechanism, and we expected no side effects from overdose or deficit serum calcium. There were no statistically significant differences in OC, the bone turnover marker, CTX and BMD. If the subject's initial serum 25(OH)D level was below 30 ng/mL, the subject was assigned to the vitamin D insufficient group; if the subject's 25(OH)D level was above 30 ng/mL, the subject was assigned to the vitamin D normal group. The 25(OH)D level was significantly higher in vitamin D insufficient group than that of the normal group (p<0.05) (Graph B). In our study, the treatment group was further divided into two, based on definition of the vitamin D insufficient group as the condition below or equal 30ng/mL vitamin D and the normal group as higher than 30ng/mL vitamin D [3, 4, 26, 27] . However, it is still controversial to define a deficiency of vitamin D. Heaney et al. [9] reported relationship between vitamin D and calcium absorption. They reported that calcium absorption rate was sharply decreased in 50.1 to 86.5 nmol/L range of vitamin D. In another study, the relationship between serum PTH and 25(OH)D required at least 72 nmol/L vitamin D which did not induce secondary hyperthyroidism [28, 29] . According to Lips' study [29] , serum PTH level would start to increase when 25(OH)D was between 30 and 78 nmol/L, however, this was also affected by many factors such as serum calcium level. They concluded that the appropriate range for serum 25(OH)D was 50 nmol/ L.
Micić I. et al.
The OC is the most important bone specific noncollagen protein and is also called Bone gla protein (BGP). It is dependent on vitamin K, which is stimulated by vitamin D and secreted by osteoblasts. Then, it circulates in the blood or is absorbed into the bone matrix. Therefore, it can be used as the bone turnover index [30] . In this study, the OC increased in post-irradiation weeks 4 and 8 in the vitamin D insufficient group, but there was no significant difference.
A calcium and vitamin D supplement is effective for preventing osteoporosis. Toss et al. [31] reported the role of UVB radiation in vitamin D deficiency groups. They divided elderly people into three groups: 1) the oral vitamin D and calcium intake group, 2) the calcium intake group, and 3) the UVB radiation group. UVB radiation was performed once a week for 3 months. The other groups took 450 IU vitamin D 2 and 420 g calcium. They reported higher serum 25(OH)D in the UVB group and vitamin D and calcium intake group. Bone ALP was decreased in the vitamin D and calcium intake group. They reported that UVB radiation was an effective and safe method for preventing the lack of vitamin D, but it was time-consuming.Meier et al. [32] reported the effects of vitamin D and calcium supply on prevention of bone loss due to seasonal variation in healthy adults. They showed the increments of BMD and vitamin D in the vitamin D deficient group compared to the controls. However, in this study, we noted little change in BMD in this elderly population.
A limitation of this study is that the effect of UVB was tested without control of the outdoor activities and diet. Further, this clinical trial was conducted over a limited period of two weeks. Comparing to our previous animal pilot study, it has been noted that even two weeks of UVB irradiation is sufficient to find difference in two groups.
CONCLUSION
In summary, UVB radiation (wavelengths between 280 and 400 nm) 30 minutes a day for two weeks added no skeletal benefit in postmenopausal women with osteoporosis during 8 weeks when assessed with BMD. However, vitamin D was increased significantly in subjects in the vitamin D insufficient group. These findings may signify the future application of UVB irradiation for the increase of serum vitamin D in the elderly with vitamin D insufficiency. However, a long-term study in a larger patient group is required to demonstrate clinical significance and confirm this finding.
КРАТАК САДРЖАЈ Увод Зна чај ви та ми на Д на гу сти ну ко сти и осте о по ро зу ис-пи ти ва ли су мно ги ис тра жи ва чи. Глав на уло га ви та ми на Д огле да се у ап сорп ци ји кал ци ју ма и фос фа та и по ве ћа њу ко шта не ми не ра ли за ци је. Код ста рих љу ди је сла би ја про-из вод ња ви та ми на Д у ко жи због сла бе из ло же но сти сун цу и сма ње њу мо гућ но сти ко же за син те зу. Циљ ра да Циљ ове кли нич ке сту ди је био је да се утвр де ефи ка сност и под но шљи вост крат ко трај ног деј ства (две не-де ље) ни ско е нер гет ског ул тра љу би ча стог (UVB) зра че ња код же на с осте о по ро зом у пост ме но па у зи ме ре њем ми-не рал не гу сти не ко сти и мар ке ра ко шта ног ме та бо ли зма. Ме то де ра да Тро ме сеч на, сле па, ран до ми зи ра на, пла це бо-кон трол на кли нич ка сту ди ја ура ђе на је у Уни вер зи тет ској бол ни ци у Де гуу, у Ју жној Ко ре ји. Пе де сет и две же не с пост-ме но па у зном осте о по ро зом (ста ри је од 65 го ди на) на су мич-но су под врг ну те деј ству ни ско е нер гет ског UVB зра че ња или пла це бо ефек ту у тра ја њу од 30 ми ну та то ком две не де ље, у зим ским ме се ци ма. Кли нич ки и ла бо ра то риј ски пре гле ди ра ђе ни су пре из ла га ња зра че њу, а по том че ти ри не де ље, осам и 12 не де ља на кон зра че ња. Ми не рал на гу сти на ко сти ме ре на је пре, а за тим осам и 12 не де ље по сле зра че ња. Ре зул та ти По ка зан је ути цај UVB зра че ња на ви та мин Д и ни во ко шта не ал кал не фос фа та зе (ALP) код же на са ин-су фи ци јен ци јом ви та ми на Д, као и по зи тив ни ефе кат на струк ту ру ко сти. У гру пи ис пи та ни ца са ин су фи ци јен ци јом ви та ми на Д уоче на је ста ти стич ки зна чај на раз ли ка у по ве-ћа њу 25(OH)D 3 у од но су на гру пу ко ја је при ма ла пла це бо (p<0,5). Ме ђу тим, ни је би ло ста ти стич ки зна чај не раз ли ке из ме ђу две гру пе у по гле ду дру гих по ка за те ља ко шта ног ме та бо ли зма (Ca, PTH-C, осте о кал цин у се ру му, се рум CTX) и ми не рал ну гу сти ну ко сти. За кљу чак Крат ко трај но из ла га ње ни ско е нер гет ском UVB зра че њу же на у пост ме но па у зи ко је бо лу ју од осте о по ро-зе мо же би ти ко ри сно у син те зи ви та ми на Д, али је уоче но ма ло по бољ ша ње у из ме ни ALP, по го то во код же на са ин-су фи ци јен ци јом ви та ми на Д. Кључ не ре чи: ни ско е нер гет ско ул тра љу би ча сто зра че ње; осте о по ро за; ми не рал на гу сти на ко сти; мар кер ко шта ног ме та бо ли зма 
